Back
Halozyme Therapeutics Stock Price Chart
Missed investing in Uber? Don't Miss Mode.
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
54
HALO
Halozyme Therapeutics
Last Price:
$50.22
Seasonality Move:
7.09%
7 Day Trial
ALL ACCESS PASS
$
7
FREE Copy of "2025 Gold Forecast: A Perfect Storm for Demand"
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report here-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.
Halozyme Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 62.72 | Sell |
| 20-day SMA: | 60.86 | Sell |
| 50-day SMA: | 61.34 | Sell |
| 200-day SMA: | 56.44 | Sell |
| 8-day EMA: | 61.45 | Sell |
| 20-day EMA: | 61.42 | Sell |
| 50-day EMA: | 60.49 | Sell |
| 200-day EMA: | 55.58 | Sell |
Halozyme Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.31 | Buy |
| Relative Strength Index (14 RSI): | 34.42 | Sell |
| Chaikin Money Flow: | -7976143 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (56.76 - 64.4) | Sell |
| Bollinger Bands (100): | (52.31 - 62.85) | Sell |
Halozyme Therapeutics Technical Analysis
| Apr 30 | May 1 | May 2 | May 5 | May 6 | May 7 | May 8 | May 9 | May 12 | May 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 30 | 01 | 02 | 05 | 06 | 07 | 08 | 09 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Halozyme Therapeutics Stock
Is Halozyme Therapeutics Stock a Buy?
-
Halozyme Therapeutics share price is 50.23 while HALO 8-day simple moving average is 62.72, which is a Sell signal.
-
The stock price of HALO is 50.23 while Halozyme Therapeutics 20-day SMA is 60.86, which makes it a Sell.
-
Halozyme Therapeutics 50-day simple moving average is 61.34 while HALO share price is 50.23, making it a Sell technically.
-
HALO stock price is 50.23 and Halozyme Therapeutics 200-day simple moving average is 56.44, creating a Sell signal.
HALO Technical Analysis vs Fundamental Analysis
Buy
54
Halozyme Therapeutics (HALO)
is a Buy
Is Halozyme Therapeutics a Buy or a Sell?
-
Halozyme Therapeutics stock is rated a BuyThe current Halozyme Therapeutics [HALO] share price is $50.23. The Score for HALO is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
Halozyme Therapeutics Stock Info
Market Cap:
6.2B
Price in USD:
50.23
Share Volume:
14M
Halozyme Therapeutics 52-Week Range
52-Week High:
70.51
52-Week Low:
42.01
Buy
54
Halozyme Therapeutics (HALO)
is a Buy
Halozyme Therapeutics Share Price Forecast
-
What is the Halozyme Therapeutics stock price today?The Halozyme Therapeutics stock price is 50.23 USD today.
-
Will HALO stock go up or go down?Halozyme Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Halozyme Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Halozyme Therapeutics is not overvalued.
Is Halozyme Therapeutics Stock a Buy?
-
Halozyme Therapeutics share price is 50.23 while HALO 8-day exponential moving average is 61.45, which is a Sell signal.
-
The stock price of HALO is 50.23 while Halozyme Therapeutics 20-day EMA is 61.42, which makes it a Sell.
-
Halozyme Therapeutics 50-day exponential moving average is 60.49 while HALO share price is 50.23, making it a Sell technically.
-
HALO stock price is 50.23 and Halozyme Therapeutics 200-day simple moving average is 55.58, creating a Sell signal.
Fundamental Analysis of Halozyme Therapeutics
Is Halozyme Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.41 per share, an increase next quarter of $0.13 per share, an increase this year of $1.17 per share, and an increase next year of $1.44 per share.
Technical Analysis of Halozyme Therapeutics
Should I short Halozyme Therapeutics stock?
-
HALO Moving Average Covergence Divergence (MACD) indicator is 0.31, suggesting Halozyme Therapeutics is a Buy
-
Halozyme Therapeutics Relative Strength Index (RSI) is 34.42, which suggest Halozyme Therapeutics is oversold
-
The Bollinger Bands (25) for Halozyme Therapeutics is (56.76 - 64.4), which suggest Halozyme Therapeutics is a Sell
-
The Bollinger Bands (100) for Halozyme Therapeutics is (52.31 - 62.85), which suggest Halozyme Therapeutics is a Sell
* Halozyme Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.